Workflow
Intel (INTC) Advances While Market Declines: Some Information for Investors
ZACKS· 2025-01-07 23:51
Stock Performance - Intel's stock closed at $20 01 with a +0 7% movement compared to the previous day outperforming the S&P 500's daily loss of 1 11% [1] - Over the past month Intel's stock has dropped by 4 52% underperforming the Computer and Technology sector's gain of 1 83% and the S&P 500's loss of 1 7% [1] Financial Forecast - Intel is forecasted to report an EPS of $0 12 a 77 78% decrease from the corresponding quarter of the prior year [2] - Quarterly revenue is expected to be $13 77 billion down 10 61% from the year-ago period [2] Analyst Estimates - Recent changes to analyst estimates for Intel reflect evolving short-term business trends with positive estimate revisions indicating a favorable business outlook [3] - The Zacks Consensus EPS estimate has decreased by 6 35% over the last 30 days and Intel currently holds a Zacks Rank of 4 (Sell) [5] Valuation Metrics - Intel's Forward P/E ratio is 21 49 which is a discount compared to the industry average of 24 42 [6] - Intel's PEG ratio is 2 02 lower than the industry average of 3 14 [6] Industry Overview - The Semiconductor - General industry part of the Computer and Technology sector has a Zacks Industry Rank of 192 placing it in the bottom 24% of all industries [7] - The top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]
Johnson & Johnson (JNJ) Advances While Market Declines: Some Information for Investors
ZACKS· 2025-01-07 23:51
Johnson & Johnson (JNJ) closed at $146.18 in the latest trading session, marking a +1.75% move from the prior day. The stock outpaced the S&P 500's daily loss of 1.11%. Elsewhere, the Dow saw a downswing of 0.42%, while the tech-heavy Nasdaq depreciated by 1.89%. Heading into today, shares of the world's biggest maker of health care products had lost 3.97% over the past month, outpacing the Medical sector's loss of 6.22% and lagging the S&P 500's loss of 1.7% in that time. Investors will be eagerly watching ...
Why the Market Dipped But Eli Lilly (LLY) Gained Today
ZACKS· 2025-01-07 23:51
Stock Performance - Eli Lilly closed at $773 29, marking a +1 07% move from the previous day, outperforming the S&P 500's daily loss of 1 11% [1] - Over the last month, Eli Lilly's shares decreased by 4 79%, surpassing the Medical sector's loss of 6 22% but falling behind the S&P 500's loss of 1 7% [1] Earnings and Revenue Expectations - The company is anticipated to report an EPS of $5 48, a 120 08% rise compared to the same quarter of the previous year [2] - Revenue is expected to be $14 06 billion, showing a 50 3% escalation compared to the year-ago quarter [2] Analyst Estimates and Revisions - Recent changes to analyst estimates reflect evolving short-term business trends, with positive revisions indicating a good sign for the company's business outlook [3] - The Zacks Consensus EPS estimate has moved 1 78% higher over the past month [5] Valuation Metrics - Eli Lilly currently trades with a Forward P/E ratio of 31 82, expressing a premium compared to the industry average of 12 34 [6] - The company's PEG ratio is 1 59, higher than the industry average of 1 26 [6] Industry Context - The Large Cap Pharmaceuticals industry, part of the Medical sector, carries a Zacks Industry Rank of 191, placing it within the bottom 24% of over 250 industries [7] - The Zacks Industry Rank shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]
Novo Nordisk (NVO) Suffers a Larger Drop Than the General Market: Key Insights
ZACKS· 2025-01-07 23:51
In the latest trading session, Novo Nordisk (NVO) closed at $83.34, marking a -1.99% move from the previous day. This move lagged the S&P 500's daily loss of 1.11%. Elsewhere, the Dow saw a downswing of 0.42%, while the tech-heavy Nasdaq depreciated by 1.89%.Shares of the drugmaker witnessed a loss of 23.45% over the previous month, trailing the performance of the Medical sector with its loss of 6.22% and the S&P 500's loss of 1.7%.Investors will be eagerly watching for the performance of Novo Nordisk in it ...
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Getty Images Holdings, Inc. - GETY
Prnewswire· 2025-01-07 23:50
Click here for more https://monteverdelaw.com/case/getty-images-holdings-inc-gety/. It is free and there is no cost or obligation to you. NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask: About Monteverde & Associates PC NEW YORK, Jan. 7, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headqu ...
Soldier who exploded Tesla Cybertruck outside Trump hotel 'used generative AI to plan attack'
Sky News· 2025-01-07 23:42
A soldier who exploded a Tesla Cybertruck outside the Trump hotel in Las Vegas used generative AI - including ChatGPT - to help plan the attack, police have said. Matthew Livelsberger, 37, a US Army Green Beret, fatally shot himself just before the truck blew up outside the hotel on New Year's Day. Police in Las Vegas say they have now reviewed Livelsberger's ChatGPT searches prior to the explosion. According to officers, the searches indicate he was looking for information on explosive targets, the speed a ...
CPRI Investors Have Opportunity to Lead Capri Holdings Limited Securities Fraud Lawsuit
Prnewswire· 2025-01-07 23:35
NEW YORK, Jan. 7, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of stock or sellers of puts of Capri Holdings Limited (NYSE: CPRI) between August 10, 2023 and October 24, 2024, both dates inclusive (the "Class Period"), of the important February 21, 2025 lead plaintiff deadline.So what: If you purchased Capri Holdings securities during the Class Period you may be entitled to compensation without payment of any o ...
Kura Sushi (KRUS) Reports Q1 Loss, Tops Revenue Estimates
ZACKS· 2025-01-07 23:26
Kura Sushi (KRUS) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.18 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 66.67%. A quarter ago, it was expected that this company would post earnings of $0.02 per share when it actually produced earnings of $0.09, delivering a surprise of 350%. Over the last four quarters, the company has surpassed ...
AAR (AIR) Q2 Earnings and Revenues Top Estimates
ZACKS· 2025-01-07 23:26
AAR (AIR) came out with quarterly earnings of $0.90 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $0.81 per share a year ago. These figures are adjusted for non- recurring items. This quarterly report represents an earnings surprise of 8.43%. A quarter ago, it was expected that this airplane maintenance company would post earnings of $0.82 per share when it actually produced earnings of $0.85, delivering a surprise of 3.66%. While AAR has underperformed the ...
Simulations Plus (SLP) Lags Q1 Earnings Estimates
ZACKS· 2025-01-07 23:26
Simulations Plus (SLP) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.10 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -5.56%. A quarter ago, it was expected that this maker of software used in pharmaceutical research would post earnings of $0.04 per share when it actually produced earnings of $0.06, delivering a surprise of 50%. ...